Wall Street trading got off to a mixed start on Friday after both the Dow Jones and S&P 500 wrapped up the previous session ...
US stocks finished in mixed fashion on Thursday, though the Dow Jones Industrial Average surged to a new all-time high on the ...
Partnering Platform Now Open for RegistrationSAN FRANCISCO--(BUSINESS WIRE)--#biotechshowcase--Biotech Showcase™ returns to ...
SAN FRANCISCO, CA / ACCESS Newswire / December 9, 2025 / Longwood Healthcare Leaders will convene top biopharmaceutical leaders at San Francisco CEO for two days of discussion, January 10-11, 2026, ...
Fintel reports that on December 4, 2025, Canaccord Genuity maintained coverage of Regeneron Pharmaceuticals (NasdaqGS:REGN) ...
Fintel reports that on December 3, 2025, Morgan Stanley downgraded their outlook for Regeneron Pharmaceuticals (NasdaqGS:REGN ...
Morgan Stanley has downgraded Regeneron Pharmaceuticals ( REGN) to equal-weight from overweight saying that the stock is fairly valued. The bank maintained its price target of $767 (~3% upside based ...
The futures are trading higher on Wednesday after a stellar day across Wall Street on Tuesday. All of the major indices ...
What began as a niche innovation within crypto markets is now shaping the future of payments. From major U.S. institutions to global players, banks are recognizing that stablecoins—blockchain-based ...
LONDON, Nov 27 (Reuters) - JPMorgan Chase & Co (JPM.N), opens new tab will build a tower in London's Canary Wharf financial district, unveiling plans on Thursday to invest billions of pounds on the ...
Detailed price information for Vera Therapeutics Inc Cl A (VERA-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback